MENU
MNKD
AS OF
Jan 14 closing price
Price
$5.61
Change
-$0.03 (-0.53%)
Capitalization
1.73B
47 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MNKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MannKind (MNKD) Ownership - Who owns MannKind?

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.73B
P/E Ratio
56.20
Total Cash
260.04M
Projected Growth
N/A
Total Debt
119.91M
Revenue
313.79M
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash/Share
0.85
Total Debt/Equity
992.55
Revenue/Share
1.02 USD as % of share price

Fundamentals

MNKD
Capitalization
1.73B
P/E Ratio
56.20
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash
260M
Total Cash/Share
0.85
Total Debt
120M
Total Debt/Equity
992.55
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.02%
Revenue
314M
ROE
N/A
Book Value
-44.55M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.07M
Current Ratio
3.29
Current Revenue Per Employee
201793.61
Dividends Per Share - Security
N/A
EBITDA
73.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.40
Revenue To Assets
6.10
Shares Held By Institutions
1.32B
Shares Outstanding - Current
307M
Total Liabilities
539M
Total Volume MTD
N/A
Value
-1
Gain YTD
-1.058
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MNKD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MNKD showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for MNKD
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com